Limits...
Visual improvement in high myopic amblyopic adult eyes following phakic anterior chamber intraocular lens implantation.

Kwon SW, Moon HS, Shyn KH - Korean J Ophthalmol (2006)

Bottom Line: The postoperative BCVA improved an average 3.92 +/- 1.24 lines over preoperative values, and mean endothelial cell loss was 8.9% at six months.The patients were all very satisfied, as the average satisfaction score was 4.3.However, long-term evaluation is necessary to assess possible complications and long-term safety.

View Article: PubMed Central - PubMed

Affiliation: Department of Ophthalmology, Gachon Medical School, Gil Medical Center, Incheon, Korea.

ABSTRACT

Purpose: To evaluate the efficacy and safety of angle-supported phakic anterior chamber intraocular lenses in amblyopic adult eyes with very high myopia.

Methods: We evaluated 12 eyes in nine patients with very high myopic amblyopia who received angle-supported phakic intraocular lenses (Phakic 6H) and followed them for more than six months. Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and complications were evaluated. A satisfaction score was rated by patients using a 5-point (1-5) numeric scale.

Results: The mean age of patients was 37.3 +/- 9.4 years, ranging from 29 to 59 years old. The preoperative mean refraction (spherical equivalent, SE) was -20.10 +/- 5.41 diopters (D). The postoperative mean refraction (SE) was -1.75 +/- 0.76 D at six months. The postoperative BCVA improved an average 3.92 +/- 1.24 lines over preoperative values, and mean endothelial cell loss was 8.9% at six months. Development of cataracts, glaucoma, and pupil abnormalities were not demonstrated in any case during the study. The patients were all very satisfied, as the average satisfaction score was 4.3.

Conclusions: This study indicates that angle-supported phakic anterior chamber intraocular lens implantation may be an effective surgical alternative for the correction of amblyopic adult eyes with very high myopia. However, long-term evaluation is necessary to assess possible complications and long-term safety.

Show MeSH

Related in: MedlinePlus

Changes in endothelial cell count following phakic anterior chamber IOL implantation.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2908833&req=5

Figure 3: Changes in endothelial cell count following phakic anterior chamber IOL implantation.

Mentions: The preoperative mean endothelial cell density was 3315±31 cells/mm2. After surgery, this decreased to 3128±512 cells/mm2 at one month, 3021±609 cells/mm2 at six months. The percentage of endothelial cell loss was 8.9% at six months (Fig. 3). The preoperative mean IOP was 14.5±1.83 mmHg. After surgery, this increased to 17.1±1.85 mmHg at one week, and 15.1±2.01 mmHg at six months. None of the patients required glaucoma therapy to control IOP elevation continuously. The preoperative mean anterior chamber depth (ACD) was 3.40±0.24 mm. At six months, the mean ACD was 3.00±0.33 mm (a 4.1% decrease).


Visual improvement in high myopic amblyopic adult eyes following phakic anterior chamber intraocular lens implantation.

Kwon SW, Moon HS, Shyn KH - Korean J Ophthalmol (2006)

Changes in endothelial cell count following phakic anterior chamber IOL implantation.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2908833&req=5

Figure 3: Changes in endothelial cell count following phakic anterior chamber IOL implantation.
Mentions: The preoperative mean endothelial cell density was 3315±31 cells/mm2. After surgery, this decreased to 3128±512 cells/mm2 at one month, 3021±609 cells/mm2 at six months. The percentage of endothelial cell loss was 8.9% at six months (Fig. 3). The preoperative mean IOP was 14.5±1.83 mmHg. After surgery, this increased to 17.1±1.85 mmHg at one week, and 15.1±2.01 mmHg at six months. None of the patients required glaucoma therapy to control IOP elevation continuously. The preoperative mean anterior chamber depth (ACD) was 3.40±0.24 mm. At six months, the mean ACD was 3.00±0.33 mm (a 4.1% decrease).

Bottom Line: The postoperative BCVA improved an average 3.92 +/- 1.24 lines over preoperative values, and mean endothelial cell loss was 8.9% at six months.The patients were all very satisfied, as the average satisfaction score was 4.3.However, long-term evaluation is necessary to assess possible complications and long-term safety.

View Article: PubMed Central - PubMed

Affiliation: Department of Ophthalmology, Gachon Medical School, Gil Medical Center, Incheon, Korea.

ABSTRACT

Purpose: To evaluate the efficacy and safety of angle-supported phakic anterior chamber intraocular lenses in amblyopic adult eyes with very high myopia.

Methods: We evaluated 12 eyes in nine patients with very high myopic amblyopia who received angle-supported phakic intraocular lenses (Phakic 6H) and followed them for more than six months. Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and complications were evaluated. A satisfaction score was rated by patients using a 5-point (1-5) numeric scale.

Results: The mean age of patients was 37.3 +/- 9.4 years, ranging from 29 to 59 years old. The preoperative mean refraction (spherical equivalent, SE) was -20.10 +/- 5.41 diopters (D). The postoperative mean refraction (SE) was -1.75 +/- 0.76 D at six months. The postoperative BCVA improved an average 3.92 +/- 1.24 lines over preoperative values, and mean endothelial cell loss was 8.9% at six months. Development of cataracts, glaucoma, and pupil abnormalities were not demonstrated in any case during the study. The patients were all very satisfied, as the average satisfaction score was 4.3.

Conclusions: This study indicates that angle-supported phakic anterior chamber intraocular lens implantation may be an effective surgical alternative for the correction of amblyopic adult eyes with very high myopia. However, long-term evaluation is necessary to assess possible complications and long-term safety.

Show MeSH
Related in: MedlinePlus